We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+17.41%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$595M
AUM Growth
+$80.2M
Cap. Flow
+$9.15M
Cap. Flow %
1.54%
Top 10 Hldgs %
24.78%
Holding
215
New
32
Increased
102
Reduced
64
Closed
13

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$7.87M
2
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$6.57M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$5.28M
4
IXUS icon
iShares Core MSCI Total International Stock ETF
IXUS
+$4.61M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.55M

Top Sells

Rank Stock Value
1
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$5.61M
2
EWG icon
iShares MSCI Germany ETF
EWG
+$4.71M
3
IWV icon
iShares Russell 3000 ETF
IWV
+$4.55M
4
AKAM icon
Akamai
AKAM
+$4.4M
5
QCOM icon
Qualcomm
QCOM
+$3.83M

Sector Composition

Rank Sector Weight
1 Technology 16.08%
2 Healthcare 14.17%
3 Financials 9.45%
4 Industrials 8.89%
5 Communication Services 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIT icon
76
Global X Lithium & Battery Tech ETF
LIT
$1.61B
$1.51M 0.25%
24,463
-67,162
-73% -$3.33M
EMQQ icon
77
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$271M
$1.51M 0.25%
+23,707
New +$1.38M
EWC icon
78
iShares MSCI Canada ETF
EWC
$6.51B
$1.45M 0.24%
46,913
+7,636
+19% +$224K
CDNA icon
79
CareDx
CDNA
$2.45B
$1.39M 0.23%
19,177
+1,491
+8% +$86.4K
REMX icon
80
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.26B
$1.36M 0.23%
+20,599
New +$1.03M
ASPN icon
81
Aspen Aerogels
ASPN
$510M
$1.35M 0.23%
80,750
+8,875
+12% +$117K
CTLP
82
DELISTED
Cantaloupe
CTLP
$1.35M 0.23%
+128,466
New +$1.26M
CMD
83
DELISTED
Cantel Medical Corporation
CMD
$1.33M 0.22%
16,930
-3,268
-16% -$192K
EBS icon
84
Emergent Biosolutions
EBS
$233M
$1.31M 0.22%
14,640
+2,939
+25% +$270K
CYRX icon
85
CryoPort
CYRX
$750M
$1.28M 0.22%
29,264
+1,771
+6% +$84.4K
GRMN
86
Garmin
GRMN
$59.8B
$1.26M 0.21%
10,538
+2,107
+25% +$233K
SMH icon
87
VanEck Semiconductor ETF
SMH
$72B
$1.25M 0.21%
11,432
-15,402
-57% -$1.53M
XLI icon
88
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
$1.21M 0.2%
13,669
-33,418
-71% -$2.82M
GOOG icon
89
Alphabet (Google) Class C
GOOG
$4.19T
$1.2M 0.2%
13,720
– –
XLV icon
90
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$1.2M 0.2%
+10,550
New +$1.15M
STE icon
91
Steris
STE
$23.1B
$1.17M 0.2%
6,160
+1,055
+21% +$197K
XLB icon
92
State Street Materials Select Sector SPDR ETF
XLB
$8.61B
$1.16M 0.2%
32,084
-16,550
-34% -$567K
OMCL icon
93
Omnicell
OMCL
$1.69B
$1.16M 0.19%
9,638
+1,317
+16% +$129K
HASI icon
94
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
$1.15M 0.19%
18,045
-1,381
-7% -$70.6K
ENV
95
DELISTED
ENVESTNET, INC.
ENV
$1.1M 0.19%
13,428
-147
-1% -$11.8K
CNMD icon
96
CONMED
CNMD
$1.48B
$1.08M 0.18%
9,643
+1,399
+17% +$132K
CSOD
97
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$1.08M 0.18%
24,441
-2,473
-9% -$102K
NGVT icon
98
Ingevity
NGVT
$2.62B
$1.07M 0.18%
14,200
+704
+5% +$45.8K
EXAS
99
DELISTED
Exact Sciences
EXAS
$1.06M 0.18%
8,039
-204
-2% -$24.7K
CDMO
100
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.05M 0.18%
90,643
+21,966
+32% +$201K
2 3
4
5 6

Similar funds

SVCP
Silicon Valley Capital Partners San Jose, California $1.02B AUM 21.85% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Greenwood Capital Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Greenwood Capital Associates held 215 positions worth $595M, up 16% from $515M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Greenwood Capital Associates's Q4 2020 filing shows 32 new, 102 increased, 64 reduced and 13 closed positions. Its largest new stake was Vertex Pharmaceuticals: 19,829 shares worth $4.69M. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $5.61M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q4 2020 buy was Vertex Pharmaceuticals: 19,829 shares worth $4.69M.
  • Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $7.87M increase.
  • Greenwood Capital Associates's biggest Q4 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $5.61M.
  • Greenwood Capital Associates fully exited Akamai in Q4 2020, selling an estimated $4.4M.
  • Greenwood Capital Associates's ten largest holdings make up 25% of its $595M portfolio in Q4 2020.
  • Greenwood Capital Associates opened 32 new positions and closed 13 in Q4 2020.
  • Greenwood Capital Associates's portfolio value rose 16% quarter-over-quarter to $595M.

Based on Greenwood Capital Associates's 13F filing for Q4 2020, filed 9 Feb 2021.